FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound having formula (I): wherein each of the groups R1, R2, R3 are independently H or C1-4 alkyl group or C2-4 acyl group; each of the groups R4 and R5 are independently H or the group of formula -SO3R6, wherein R6 is H or the C1-4 alkyl group or the C2-4 acyl group; provided at least one of the groups R4 and R5 is a group having formula -SO3R6, or a pharmaceutically acceptable salt thereof. The invention also refers to a method for preparing the specified compounds of formula (I) and a pharmaceutical composition possessing activity in the inhibition of IL-1 anti-inflammatory cytokines based on these compounds.
EFFECT: there are produced new compounds and pharmaceutical composition on their basis which can find application in medicine for treating an inflammatory or autoimmune condition.
17 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
DIACEREIN OR ANALOGUES THEREOF FOR INHIBITING ASC EXPRESSION, NLRP3 EXPRESSION AND/OR COMPLEXING OF NLRP3 INFLAMMASOMES | 2016 |
|
RU2729066C2 |
METHODS AND COMPOSITIONS FOR TREATING HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA | 2012 |
|
RU2603050C2 |
USING CARBOXY-AMIDO-TRIAZOLES AND THEIR SALTS | 2007 |
|
RU2448704C2 |
PROPHYLAXIS AND TREATMENT OF INFECTIOUS AND OTHER DISEASES BY USING COMPOUNDS BASED ON MONO- N DISACCHARIDES | 2001 |
|
RU2289410C2 |
FUNCTIONALIZED SACCHARIDES AS ANTI-INFLAMMATORY AGENTS | 2018 |
|
RU2772214C2 |
SUBSTANCES USABLE FOR TREATING PSORIASIS CASES | 2001 |
|
RU2266740C2 |
NOVEL AMINOALKYLGLUCOSAMINIDE PHOSPHATE COMPOUNDS, IMMUNOSTIMULATING PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND METHOD FOR INDUCING IMMUNE RESPONSE | 2002 |
|
RU2289585C2 |
INHIBITORS OF ENZYMES CONVERTING 1β-INTERLEUKIN | 1996 |
|
RU2213096C2 |
CHEMICAL COMPOUNDS | 2008 |
|
RU2462472C2 |
INHIBITORS OF NO-SYNTHASE BASED ON MERCAPTO- AND SELENODERIVATIVES | 1996 |
|
RU2191575C2 |
Authors
Dates
2013-05-20—Published
2008-11-14—Filed